You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 477 COM902 (Anti-TIGIT antibody) monotherapy – preliminary evaluation of safety, tolerability, pharmacokinetics and receptor occupancy in patients with advanced solid tumors (NCT04354246)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
477 COM902 (Anti-TIGIT antibody) monotherapy – preliminary evaluation of safety, tolerability, pharmacokinetics and receptor occupancy in patients with advanced solid tumors (NCT04354246)
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to October 2024

AbstractFullPdf
Nov 2021758029
Dec 20218409
Jan 2022128010
Feb 202256012
Mar 202220408
Apr 202210606
May 202250012
Jun 202246016
Jul 202244011
Aug 20224006
Sep 202256015
Oct 202284014
Nov 20223408
Dec 20223802
Jan 20236206
Feb 20235806
Mar 20237204
Apr 20233608
May 20234807
Jun 20236408
Jul 20236409
Aug 20239408
Sep 20233801
Oct 20237004
Nov 20236807
Dec 20237406
Jan 20243003
Feb 20244602
Mar 20245008
Apr 20246409
May 202492010
Jun 20247205
Jul 2024100014
Aug 202464010
Sep 20245605
Oct 202468010
Total31180308